Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Cytokinetics Inc shares valued at $611,250 were sold by Blum Robert I on Mar 31 ’25. At $40.75 per share, Blum Robert I sold 15,000 shares. The insider’s holdings dropped to 427,629 shares worth approximately $17.21 million following the completion of this transaction.
Also, Malik Fady Ibraham sold 2,000 shares, netting a total of over 87,160 in proceeds. Following the sale of shares at $43.58 each, the insider now holds 140,455 shares.
Before that, Callos Andrew had sold 2,775 shares from its account. In a trade valued at $123,154, the EVP, Chief Commercial Officer traded Cytokinetics Inc shares for $44.38 each. Upon closing the transaction, the insider’s holdings decreased to 2,775 shares, worth approximately $1.4 million.
As published in their initiating research note from Citigroup on February 07, 2025, Cytokinetics Inc [CYTK] has been a Buy and the price target has been revised to $86. Analysts at Stifel started covering the stock with ‘”a Buy”‘ outlook in a report released in late January. As of November 08, 2024, RBC Capital Mkts has initiated its “an Outperform” rating for CYTK. Earlier on August 13, 2024, Goldman downgraded its rating. Their new recommendation was “a Neutral” for CYTK stock which previously was a “a Buy”.
Analyzing CYTK Stock Performance
During the last five days, there has been a drop of approximately -7.75%. Over the course of the year, Cytokinetics Inc shares have dropped approximately -14.43%. Shares of the company reached a 52-week high of $52.80 on 01/27/25 and a 52-week low of $37.46 on 04/01/25. A 50-day SMA is recorded $45.36, while a 200-day SMA reached $51.28.
Support And Resistance Levels for Cytokinetics Inc (CYTK)
According to the 24-hour chart, there is a support level at 39.04, which, if violated, would cause prices to drop to 37.84. In the upper region, resistance lies at 42.57. The next price resistance is at 44.90. RSI (Relative Strength Index) is 40.40 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -3.79, which suggests the price will decrease in the coming days. Percent R is at 74.57%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
